ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Clinical Infectious Diseases
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1606509
This article is part of the Research TopicExploring Immunometabolism: Metabolic Pathway and Immune Response in SepsisView all 4 articles
Deciphering the role of SEMA4A/MAPK signaling in sepsis: insights from Mendelian randomization, transcriptomic, single-cell sequencing analyses, and vitro experiments
Provisionally accepted
Meng-Qin PeiYan-Ling LinLi-Ming XuYu-Shen YangZhen-Dong SunYa-Fen ZengGui-Dan Wang
He-fan He*Li-Ying Yu- The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Sepsis is a condition with high mortality and multiple organ dysfunction, undergoing complex pathogenesis and limited treatment options. This study aims to uncover new therapeutic targets for sepsis Methods: Three independent transcriptomic datasets from sepsis patients in the GEO database were utilized. Batch effect correction and differential gene expression analysis were performed to identify differentially expressed genes (DEGs), followed by mendelian randomization (MR) analysis to identify sepsis-related risk genes. The intersection of DEGs and MR risk genes revealed final core sepsis genes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted to elucidate the functional pathways of core genes.Single-cell RNA sequencing (scRNA-seq) analysis was employed to evaluate gene expression profiles across various cell types in sepsis. In vitro experiments were performed to validate pathways associated with the core genes.We identified 307 highly expressed DEGs and 72 disease-related risk genes, culminating in the identification of three core sepsis genes including SEMA4A, LRPAP1, and NTSR1. These genes are involved in biological processes and pathways related to immune responses, such as immune rejection. scRNA-seq data indicated that three core sepsis genes are predominantly expressed in monocytes. In vitro experiments using THP-1 human monocytic cells validated that SEMA4A as well as the MAPK biomarker gene ERK were up-regulated in LPS-induced sepsis cells.This study proposes SEMA4A, LRPAP1, and NTSR1 as promising therapeutic targets for sepsis. Particularly, it underscores the crucial role of SEMA4A/MAPK in monocytes in the pathogenesis and progression of sepsis, offering valuable insights for potential treatment strategies.
Keywords: ：SEMA4A, Sepsis, Mendelian randomization, Transcriptomics, single-cell sequencing
Received: 05 Apr 2025; Accepted: 25 Jun 2025.
Copyright: © 2025 Pei, Lin, Xu, Yang, Sun, Zeng, Wang, He and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: He-fan He, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.